p.75 抽出テキスト

physiol 2019; 5: 295-305. PMID: 30898231 240. Sato T, Sotomi Y, Hikoso S, et al. Osaka Cardio Vascular Conference (OCVC)‐Arrhythmia Investigators. DR-FLASH score is useful for identifying patients with persistent atrial fibrillation who require extensive catheter ablation procedures. J Am Heart Assoc 2022; 11: e024916. PMID: 35929474 241. Kistler PM, Chieng D, Sugumar H, et al. Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the CAPLA randomized clinical trial. JAMA 2023; 329: 127-135. PMID: 36625809 242. Kim D, Yu HT, Kim TH, et al. Electrical posterior box isolation in repeat ablation for atrial fibrillation: a prospective randomized clinical study. JACC Clin Electrophysiol 2022; 8: 582- 592. PMID: 35589170 243. Yamaji H, Higashiya S, Murakami T, et al. Efficacy of an adjunctive electrophysiological test-guided left atrial posterior wall isolation in persistent atrial fibrillation without a left atrial low-voltage area. Circ Arrhythm Electrophysiol 2020; 13: e 008191. PMID: 32660260 244. Ahn J, Shin DG, Han SJ, et al. Does isolation of the left atrial posterior wall using cryoballoon ablation improve clinical outcomes in patients with persistent atrial fibrillation? A prospective randomized controlled trial. Europace 2022; 24: 1093-1101. PMID: 35138376 245. Aryana A, Allen SL, Pujara DK, et al. Concomitant pulmonary vein and posterior wall isolation using cryoballoon with adjunct radiofrequency in persistent atrial fibrillation. JACC Clin Electrophysiol 2021; 7: 187-196. PMID: 33602399 246. Jiang X, Liao J, Ling Z, et al. Adjunctive left atrial posterior wall isolation in treating atrial fibrillation: insight from a large secondary analysis. JACC Clin Electrophysiol 2022; 8: 605-618. PMID: 35589173 247. Thiyagarajah A, Kadhim K, Lau DH, et al. Feasibility, safety, and efficacy of posterior wall isolation during atrial fibrillation ablation: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol 2019; 12: e007005. PMID: 31401853 248. Rolf S, Kircher S, Arya A, et al. Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 2014; 7: 825- 833. PMID: 25151631 249. Kircher S, Arya A, Altmann D, et al. Individually tailored vs. standardized substrate modification during radiofrequency catheter ablation for atrial fibrillation: a randomized study. Europace 2018; 20: 1766-1775. PMID: 29177475 250. Yang G, Zheng L, Jiang C, et al. STABLE-SR-II Investigators. Circumferential pulmonary vein isolation plus low-voltage area modification in persistent atrial fibrillation: the STABLE-SR-II trial. JACC Clin Electrophysiol 2022; 8: 882- 891. PMID: 35863814 251. Masuda M, Asai M, Iida O, et al. Additional low-voltage-area ablation in patients with paroxysmal atrial fibrillation: results of the randomized controlled VOLCANO trial. J Am Heart Assoc 2020; 9: e015927. PMID: 32578466 252. Huo Y, Gaspar T, Schönbauer R, et al. Low-voltage myocardiumguided ablation trial of persistent strial fibrillation. NEJM Evid 2022; 1. doi: 10.1056/EVIDoa2200141 253. Chen H, Li C, Han B, et al. STABLE-SR-III Investigators. Circumferential pulmonary vein isolation with vs without additional low-voltage-area ablation in older patients with paroxysmal atrial fibrillation: a randomized clinical trial. JAMA Cardiol 2023; 8: 765-772. PMID: 37378966 254. Junarta J, Siddiqui MU, Riley JM, et al. Low-voltage area substrate modification for atrial fibrillation ablation: a systematic review and meta-analysis of clinical trials. Europace 2022; 24: 1585-1598. PMID: 35696286 255. Yamaguchi T, Otsubo T, Takahashi Y, et al. Atrial structural remodeling in patients with atrial fibrillation is a diffuse fibrotic process: evidence from high-density voltage mapping and atrial biopsy. J Am Heart Assoc 2022; 11: e024521. PMID: 35261287 256. Hwang C, Chen PS. Ligament of Marshall: why it is important for atrial fibrillation ablation. Heart Rhythm 2009; 6 Suppl: S35-S40. PMID: 19959141 257. Valderrábano M, Chen HR, Sidhu J, et al. Retrograde ethanol infusion in the vein of Marshall: regional left atrial ablation, vagal denervation and feasibility in humans. Circ Arrhythm Electrophysiol 2009; 2: 50-56. PMID: 19756206 258. Valderrábano M, Peterson LE, Swarup V, et al. Effect of catheter ablation with vein of Marshall ethanol infusion vs catheter ablation alone on persistent atrial fibrillation: the VENUS randomized clinical trial. JAMA 2020; 324: 1620-1628. PMID: 33107945 259. Mhanna M, Beran A, Al-Abdouh A, et al. Adjunctive vein of Marshall ethanol infusion during atrial fibrillation ablation: a systematic review and meta-analysis. J Atr Fibrillation 2021; 14: 20200492. PMID: 34950366 260. Hirokami J, Hiroshima K, Yamaji K, et al. Relationship between fractionated signal areas in the atrial muscle during sinus rhythm and atrial pacing and non-pulmonary vein foci: novel mapping strategy. Circ Arrhythm Electrophysiol 2020; 13: e008667. PMID: 32628515 261. Chen J, Arentz T, Cochet H, et al. Extent and spatial distribution of left atrial arrhythmogenic sites, late gadolinium enhancement at magnetic resonance imaging, and low-voltage areas in patients with persistent atrial fibrillation: comparison of imaging vs. electrical parameters of fibrosis and arrhythmogenesis. Europace 2019; 21: 1484-1493. PMID: 31280323 262. Di Biase L, Burkhardt JD, Mohanty P, et al. Left atrial appendage isolation in patients with longstanding persistent AF undergoing catheter ablation: BELIEF trial. J Am Coll Cardiol 2016; 68: 1929- 1940. PMID: 27788847 263. Zedda A, Huo Y, Kronborg M, et al. Left atrial isolation and appendage occlusion in patients with atrial fibrillation at end-stage left atrial fibrotic disease. Circ Arrhythm Electrophysiol 2021; 14: e010011. PMID: 34270906 264. Wazni OM, Dandamudi G, Sood N, et al. STOP AF First Trial Investigators. Cryoballoon ablation as initial therapy for atrial fibrillation. N Engl J Med 2021; 384: 316-324. PMID: 33197158 265. Andrade JG, Wells GA, Deyell MW, et al. EARLY-AF Investigators. Cryoablation or drug therapy for initial treatment of atrial fibrillation. N Engl J Med 2021; 384: 305-315. PMID: 33197159 266. Kuniss M, Pavlovic N, Velagic V, et al. Cryo-FIRST Investigators. Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation. Europace 2021; 23: 1033-1041. PMID: 33728429 267. Andrade JG, Wazni OM, Kuniss M, et al. Cryoballoon ablation as initial treatment for atrial fibrillation: JACC state-of-the-art review. J Am Coll Cardiol 2021; 78: 914-930. PMID: 34446164 268.  Karl-Heinz K, Brugada J, Fürnkranz A, et al. FIRE AND ICE Investigators. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 2016; 374: 2235- 2245. PMID: 27042964 269.  Sørensen SK, Johannessen A, Worck R, et al. Radiofrequency versus cryoballoon catheter ablation for paroxysmal atrial fibrillation: durability of pulmonary vein isolation and effect on atrial fibrillation burden: the RACE-AF randomized controlled trial. Circ Arrhythm Electrophysiol 2021; 14: e009573. PMID: 33835823 270.  Andrade JG, Champagne J, Dubuc M, et al. CIRCA-DOSE Study Investigators. Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial. Circulation 2019; 140: 1779-1788. PMID: 31630538 271. Kirchhof P, Camm AJ, Goette A, et al. EAST-AFNET 4 Trial Investigators. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med 2020; 383: 1305-1316. PMID: 32865375 272. Willems S, Borof K, Brandes A, et al. Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial. Eur Heart J 2022; 43: 1219- 1230. PMID: 34447995 273. Rillig A, Borof K, Breithardt G, et al. Early rhythm control in patients with atrial fibrillation and high comorbidity burden. Circulation 2022; 146: 836-847. PMID: 35968706 274. Kim JY, Park HS, Park HW, et al. Clinical outcomes of rhythm control strategies for asymptomatic atrial fibrillation according to the quality-of-life score: the CODE-AF (Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation) registry. J Am Heart Assoc 2022; 11: e025956. PMID: 36073646 275. Kuck KH, Lebedev DS, Mikhaylov EN, et al. Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST). Europace 2021; 23: 362-369. PMID: 33330909 276. Andrade JG, Deyell MW, Macle L, et al. EARLY-AF Investigators. Progression of atrial fibrillation after cryoablation or drug therapy. N Engl J Med 2023; 388: 105-116. PMID: 36342178 277. Packer DL, Mark DB, Robb RA, et al. CABANA Investigators. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA 2019; 321: 1261-1274. PMID: 30874766 278. Simader FA, Howard JP, Ahmad Y, et al. Catheter ablation improves cardiovascular outcomes in patients with atrial fibrilla-